Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2021   |   Volume: 10   |   Issue: 5   |   Page: 225-226     View issue

Serous tubal intraepithelial carcinoma: Emerging trend in ovarian neoplasm: A must know for a pathologist


Abstract

Among all gynecological malignancies, ovarian cancer is associated with the highest rate of mortality. Most ovarian carcinomas have been suggested to originate from the ovarian surface epithelium or postovulatory inclusion cysts formed after follicular rupture and repair. Over the past decade, a new model has emerged to explain the origin of epithelial tumors of the ovary and the fallopian tube now appears to play a central role; however, there is now compelling evidence that many epithelial pelvic cancers, especially high-grade serous carcinomas of the ovary/peritoneum, begin in the mucosa of the fallopian tube as serous tubal intraepithelial carcinoma.

Cite this article
Vancouver
Iqbal B. Serous tubal intraepithelial carcinoma: Emerging trend in ovarian neoplasm: A must know for a pathologist. Clin Cancer Investig J. 2021;10(5):225-6. https://doi.org/10.4103/ccij.ccij_46_21
APA
Iqbal, B. (2021). Serous tubal intraepithelial carcinoma: Emerging trend in ovarian neoplasm: A must know for a pathologist. Clinical Cancer Investigation Journal, 10(5), 225-226. https://doi.org/10.4103/ccij.ccij_46_21

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513